Biotech Values

[mcbio]

Anyone else thinking that at some point Roche/Genentech reaquires them?

The ChK-1 drugs you mean? Hard to say, but keep in mind there's the partnered Akt drug as well in Phase 1 with Roche/Genentech.

I may get a few shares again with that being the "safety net". I am slowly to act and a bit greedy so it'll probably pop next week before I buy and all the Array longs can thank me...or it'll drop a bit and I'll buy then it'll really drop and all the longs can yell at me .

I stand prepared to act on your latter point. ; )

Thanks for the ReadMe was helpful and nice for looking up some of the royalties would be helpful if you had rates for us lazy people .

No prob. I don't think a lot of the specific royalties have been disclosed. Of the key drugs, we know that selumetinib is apparently single-digit at some sales level before crossing into double-digit but the MEK162 deal with NVS gives ARRY double-digit royalties at all sales levels. And, knowing you, you will probably like the fact that ARRY apparently has no plans to try to co-develop MEK162 going forward and will just rely on NVS to bear all expenses in exchange for double-digit royalties. (I'm happy with that myself as they need to focus on keeping costs to a minimum.)

P.S. ARRY had another insider transaction as a director just purchased 5,000 shares yesterday. This goes along with the multiple recent purchases from Conway.